Cookies used for improved website experience

Siemens Healthineers and our partners use cookies and other similar technologies to operate the Siemens Healthineers websites and personalize content and ads. You may find out more about how we use cookies by clicking "Show details" or by referring to our Cookie Policy.
You may allow all cookies or select them individually. And you may change your consent and cookie preferences anytime by clicking on the "Review and change your consent" button on the Cookie Policy page.

CK-MB MassAn alternative to Tropinin I that aids in diagnosing acute myocardial infarction

The Acute Care™ CK-MB assay is an in vitro diagnostic test for the measurement of the MB iso-enzyme of creatine kinase in heparinized whole blood/plasma. CK-MB measurements can be used as an aid in diagnosing acute myocardial infarction.

  • One sample, one run, one instrument; increases efficiency in triaging chest pain patients
  • Rapid turnaround time - in as little as 14 minutes (with onboard centrifugation)
  • Heparinized whole blood samples

Features & Benefits

  • One sample, one run, one instrument; increases efficiency in triaging chest pain patients
  • Rapid turnaround time - in as little as 14 minutes (with onboard centrifugation)
  • Single and ready to use TestPak™ Cartridges
    • No reconstitution
    • No warming to room temperature
    • Reduction in reagent waste
    • Reduction in contamination
  • Heparinized whole blood samples
  • Electronic QC (System Check) satisfies daily routine QC requirements permitting liquid QC flexibility
     

Clinical Use

CK-MB is found primarily in cardiac tissue.1 CK-MB can be detected at elevated concentrations following myocardial damage. Abnormal plasma CK-MB concentrations are often associated with ischemia or necrotic heart injury. The increase in CK-MB concentration is often evident within 3 to 6 hours following onset of chest pain, reaching peak concentrations within 12 to 24 hours. CK-MB concentrations will generally return to normal within 24 to 72 hours.2 The determination of CK-MB is most beneficial when samples have been drawn at appropriate time intervals post onset of chest pain.

Technical Specifications

βhCG

Assay Range

0.3 – 150ng/mL (µg/L)

Sensitivity

0.3 ng/mL

Reproducibility (CV)

4.0% at 3.7 ng/mL

Calibration Stability

60 days

DilPak™ Automatic Dilution

Yes

Sodium Heparin Tubes

Yes

Lithium Heparin Tubes

Yes

1
2